Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 296 (112th)

Preserving Access to Life-Saving Medications Act

referredUnited States· United States Congress· EN

Introduced

7 February 2011

Last action

7 February 2011 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Sen. Klobuchar, Amy [D-MN], Sen. Casey, Robert P., Jr. [D-PA], Sen. Blumenthal, Richard [D-CT], Sen. Cardin, Benjamin L. [D-MD], Sen. Brown, Sherrod [D-OH], Sen. Schumer, Charles E. [D-NY], Sen. Tester, Jon [D-MT], Sen. Coons, Christopher A. [D-DE], Sen. Feinstein, Dianne [D-CA], Sen. Franken, Al [D-MN], Sen. Mikulski, Barbara A. [D-MD], Sen. Reed, Jack [D-RI], Sen. Collins, Susan M. [R-ME], Sen. Johnson, Tim [D-SD], Sen. Bingaman, Jeff [D-NM], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Reid, Harry [D-NV], Sen. Landrieu, Mary L. [D-LA], Sen. McCaskill, Claire [D-MO], Sen. Merkley, Jeff [D-OR], Sen. Cantwell, Maria [D-WA], Sen. Shaheen, Jeanne [D-NH], Sen. Stabenow, Debbie [D-MI], Sen. Warner, Mark R. [D-VA], Sen. Sanders, Bernard [I-VT], Sen. Durbin, Richard J. [D-IL], Sen. Lautenberg, Frank R. [D-NJ], Sen. Leahy, Patrick J. [D-VT], Sen. Udall, Tom [D-NM], Sen. Nelson, Bill [D-FL], Sen. Conrad, Kent [D-ND]

Subjects

Healthcare

Source updated

14 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Preserving Access to Life-Saving Medications Act - Amends the Federal Food, Drug, and Cosmetic Act to require a prescription drug manufacturer to notify the Secretary of Health and Human Services (HHS) of a discontinuance, interruption, or other adjustment of the manufacture of the drug that would likely result in a shortage of such drug. Requires: (1) six months notice of any discontinuance or planned interruption or adjustment, and (2) notice as soon as practicable after becoming aware of such interruption or adjustment in the case of any other interruption or adjustment. Applies this Act to any approved prescription drug that is not a product that was originally derived from human tissue and was replaced by a recombinant product. Sets forth the types of adjustment for which a manufacturer must submit notice, including: (1) adjustments related to the supply of raw materials, (2) adjustments to production capabilities, (3) business decisions that may affect the manufacture of the drug, and (4) other adjustments as determined appropriate by the Secretary.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 7 February 2011

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

  2. 7 February 2011

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 7 February 2011

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 7 February 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 7 February 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.